Latest Breaking News On - Head of medical affairs at alnylam pharmaceuticals - Page 1 : comparemela.com

Scholar Rock Appoints Jing L Marantz, M D , Ph D , M B A , as Chief Medical Officer

09.11.2022 - Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced the appointment of Jing L. Marantz, M.D., Ph.D., . Seite 1

Jay backstromHead of medical affairs at acceleron pharmaHead of medical affairs at alnylam pharmaceuticalsGlobal affairsUs medical affairsMillennium pharmaceuticalsBusiness wireScholar rockChief medicalChief executive officerExecutive vice presidentChief business officerSenior vice presidentMedical affairsAlnylam pharmaceuticalsVice president

Arcturus Therapeutics Appoints Jing Marantz, M D , Ph D , M B A to its Board of Directors

Arcturus Therapeutics Appoints Jing Marantz, M D , Ph D , M B A to its Board of Directors
news8000.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news8000.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoJing marantzCarlo tanziJingl marantzJoseph payneDeepankar royKrystal biotech incGlobal medical affairsJanssen pharmaceuticals incCystic fibrosis foundationJanssen pharmaceutical companies of johnsonTakeda pharmaceutical companyMerck co incHead of medical affairs at alnylam pharmaceuticalsUs medical affairs

Arcturus Therapeutics Appoints Jing Marantz, M D , Ph D , M B A to its Board of Directors

Arcturus Therapeutics Appoints Jing Marantz, M D , Ph D , M B A to its Board of Directors
kxly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kxly.com Daily Mail and Mail on Sunday newspapers.

Arcturus Therapeutics Appoints Jing Marantz, M D , Ph D , M B A to its Board of Directors

Arcturus Therapeutics Holdings Inc. , a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and. | December 13, 2021

United statesSan diegoJing marantzJingl marantzJoseph payneKrystal biotech incGlobal medical affairsJanssen pharmaceuticals incCystic fibrosis foundationJanssen pharmaceutical companies of johnsonTakeda pharmaceutical companyMerck co incHead of medical affairs at alnylam pharmaceuticalsUs medical affairsUltragenyx pharmaceutical incArcturus therapeutics holdings inc